Cargando…

Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer

The association between cell proliferation and the malignant potential of colon cancer is not well understood. Here, we evaluated this association using a colon-specific gene proliferation signature (GPS). The GPS was derived by combining gene expression data obtained from the analysis of a cancer c...

Descripción completa

Detalles Bibliográficos
Autores principales: Anjomshoaa, A, Lin, Y-H, Black, M A, McCall, J L, Humar, B, Song, S, Fukuzawa, R, Yoon, H-S, Holzmann, B, Friederichs, J, van Rij, A, Thompson-Fawcett, M, Reeve, A E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538751/
https://www.ncbi.nlm.nih.gov/pubmed/19238634
http://dx.doi.org/10.1038/sj.bjc.6604560
_version_ 1782159129082593280
author Anjomshoaa, A
Lin, Y-H
Black, M A
McCall, J L
Humar, B
Song, S
Fukuzawa, R
Yoon, H-S
Holzmann, B
Friederichs, J
van Rij, A
Thompson-Fawcett, M
Reeve, A E
author_facet Anjomshoaa, A
Lin, Y-H
Black, M A
McCall, J L
Humar, B
Song, S
Fukuzawa, R
Yoon, H-S
Holzmann, B
Friederichs, J
van Rij, A
Thompson-Fawcett, M
Reeve, A E
author_sort Anjomshoaa, A
collection PubMed
description The association between cell proliferation and the malignant potential of colon cancer is not well understood. Here, we evaluated this association using a colon-specific gene proliferation signature (GPS). The GPS was derived by combining gene expression data obtained from the analysis of a cancer cell line model and a published colon crypt profile. The GPS was overexpressed in both actively cycling cells in vitro and the proliferate compartment of colon crypts. K-means clustering was used to independantly stratify two cohorts of colon tumours into two groups with high and low GPS expression. Notably, we observed a significant association between reduced GPS expression and an increased likelihood of recurrence (P<0.05), leading to shorter disease-free survival in both cohorts. This finding was not a result of methodological bias as we verified the well-established association between breast cancer malignancy and increased proliferation, by applying our GPS to public breast cancer data. In this study, we show that reduced proliferation is a biological feature characterizing the majority of aggressive colon cancers. This contrasts with many other carcinomas such as breast cancer. Investigating the reasons underlying this unusual observation may provide important insight into the biology of colon cancer progression and putative novel therapy options.
format Text
id pubmed-2538751
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-25387512009-09-16 Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer Anjomshoaa, A Lin, Y-H Black, M A McCall, J L Humar, B Song, S Fukuzawa, R Yoon, H-S Holzmann, B Friederichs, J van Rij, A Thompson-Fawcett, M Reeve, A E Br J Cancer Genetics and Genomics The association between cell proliferation and the malignant potential of colon cancer is not well understood. Here, we evaluated this association using a colon-specific gene proliferation signature (GPS). The GPS was derived by combining gene expression data obtained from the analysis of a cancer cell line model and a published colon crypt profile. The GPS was overexpressed in both actively cycling cells in vitro and the proliferate compartment of colon crypts. K-means clustering was used to independantly stratify two cohorts of colon tumours into two groups with high and low GPS expression. Notably, we observed a significant association between reduced GPS expression and an increased likelihood of recurrence (P<0.05), leading to shorter disease-free survival in both cohorts. This finding was not a result of methodological bias as we verified the well-established association between breast cancer malignancy and increased proliferation, by applying our GPS to public breast cancer data. In this study, we show that reduced proliferation is a biological feature characterizing the majority of aggressive colon cancers. This contrasts with many other carcinomas such as breast cancer. Investigating the reasons underlying this unusual observation may provide important insight into the biology of colon cancer progression and putative novel therapy options. Nature Publishing Group 2008-09-16 2008-08-26 /pmc/articles/PMC2538751/ /pubmed/19238634 http://dx.doi.org/10.1038/sj.bjc.6604560 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Genetics and Genomics
Anjomshoaa, A
Lin, Y-H
Black, M A
McCall, J L
Humar, B
Song, S
Fukuzawa, R
Yoon, H-S
Holzmann, B
Friederichs, J
van Rij, A
Thompson-Fawcett, M
Reeve, A E
Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer
title Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer
title_full Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer
title_fullStr Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer
title_full_unstemmed Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer
title_short Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer
title_sort reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer
topic Genetics and Genomics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538751/
https://www.ncbi.nlm.nih.gov/pubmed/19238634
http://dx.doi.org/10.1038/sj.bjc.6604560
work_keys_str_mv AT anjomshoaaa reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer
AT linyh reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer
AT blackma reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer
AT mccalljl reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer
AT humarb reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer
AT songs reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer
AT fukuzawar reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer
AT yoonhs reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer
AT holzmannb reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer
AT friederichsj reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer
AT vanrija reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer
AT thompsonfawcettm reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer
AT reeveae reducedexpressionofageneproliferationsignatureisassociatedwithenhancedmalignancyincoloncancer